Skip to content

Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments

Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00925483
Enrollment
60
Registered
2009-06-22
Start date
2004-08-31
Completion date
Unknown
Last updated
2010-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

left ventricular mass, cardiac MRI, long dialysis, daily dialysis

Brief summary

Given the known increased risk of heart disease in hemodialysis patients, this study aims to evaluate the change in both size and function of the heart by using cardiac magnetic resonance imaging (MRI) in patients undergoing either daily long (4 hours, 6 times weekly), daily short (2 hours 6 times weekly), or alternate day conventional (4 hours, 3 times weekly) and alternate day long (8 hours, 3 times weekly) dialysis for 6 months from randomization. The patients are randomly put in the groups based on predetermined randomization schedule and the cardiologist trained in cardiac MRI readings is blinded to the patient treatment schedule. Given that changes in heart function may be seen with cardiac imaging techniques within 6 months, the expectation is that groups on daily treatment may have better outcome for this parameter as changes in volume and blood pressure may also be affected in a positive way in patients on daily dialysis.

Interventions

PROCEDUREdialysis

different dialysis schedules for each arm

Sponsors

Dallas VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* End stage renal disease patients on hemodialysis

Exclusion criteria

* Weight \> 350 lbs * Known poor dialysis and or treatment compliance * Unable to come for daily treatments if randomization occurs in this group * Prognosis less than 6 months * Difficulty in tolerating dialysis and possibility of discontinuation of dialysis before 6 months

Design outcomes

Primary

MeasureTime frame
LVM change per Cardiac MRI6 months

Countries

United States

Contacts

Primary ContactDevasmita C. Dev, MD
Devasmita.dev@med.va.gov214-857-1593

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026